These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Stage-specific effects of a thiazolidinedione on proliferation, differentiation and PPARgamma mRNA expression in 3T3-L1 adipocytes. Takamura T; Nohara E; Nagai Y; Kobayashi K Eur J Pharmacol; 2001 Jun; 422(1-3):23-9. PubMed ID: 11430909 [TBL] [Abstract][Full Text] [Related]
3. The short- and long-term effects of tumor necrosis factor-alpha and BRL 49653 on peroxisome proliferator-activated receptor (PPAR)gamma2 gene expression and other adipocyte genes. Rosenbaum SE; Greenberg AS Mol Endocrinol; 1998 Aug; 12(8):1150-60. PubMed ID: 9717841 [TBL] [Abstract][Full Text] [Related]
4. A selective peroxisome proliferator-activated receptor-gamma (PPARgamma) modulator blocks adipocyte differentiation but stimulates glucose uptake in 3T3-L1 adipocytes. Mukherjee R; Hoener PA; Jow L; Bilakovics J; Klausing K; Mais DE; Faulkner A; Croston GE; Paterniti JR Mol Endocrinol; 2000 Sep; 14(9):1425-33. PubMed ID: 10976920 [TBL] [Abstract][Full Text] [Related]
5. Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha. Zhang B; Berger J; Hu E; Szalkowski D; White-Carrington S; Spiegelman BM; Moller DE Mol Endocrinol; 1996 Nov; 10(11):1457-66. PubMed ID: 8923470 [TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction. Meng L; Zhou J; Sasano H; Suzuki T; Zeitoun KM; Bulun SE Cancer Res; 2001 Mar; 61(5):2250-5. PubMed ID: 11280794 [TBL] [Abstract][Full Text] [Related]
7. Induction of the nuclear orphan receptor RORgamma during adipocyte differentiation of D1 and 3T3-L1 cells. Austin S; Medvedev A; Yan ZH; Adachi H; Hirose T; Jetten AM Cell Growth Differ; 1998 Mar; 9(3):267-76. PubMed ID: 9543393 [TBL] [Abstract][Full Text] [Related]
8. A novel potent antagonist of peroxisome proliferator-activated receptor gamma blocks adipocyte differentiation but does not revert the phenotype of terminally differentiated adipocytes. Camp HS; Chaudhry A; Leff T Endocrinology; 2001 Jul; 142(7):3207-13. PubMed ID: 11416043 [TBL] [Abstract][Full Text] [Related]
9. Down regulation of peroxisome proliferator-activated receptorgamma expression by inflammatory cytokines and its reversal by thiazolidinediones. Tanaka T; Itoh H; Doi K; Fukunaga Y; Hosoda K; Shintani M; Yamashita J; Chun TH; Inoue M; Masatsugu K; Sawada N; Saito T; Inoue G; Nishimura H; Yoshimasa Y; Nakao K Diabetologia; 1999 Jun; 42(6):702-10. PubMed ID: 10382590 [TBL] [Abstract][Full Text] [Related]
10. A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor gamma agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation. Burris TP; Pelton PD; Zhou L; Osborne MC; Cryan E; Demarest KT Mol Endocrinol; 1999 Mar; 13(3):410-7. PubMed ID: 10076998 [TBL] [Abstract][Full Text] [Related]
11. Differential gene regulation by PPARgamma agonist and constitutively active PPARgamma2. Li Y; Lazar MA Mol Endocrinol; 2002 May; 16(5):1040-8. PubMed ID: 11981038 [TBL] [Abstract][Full Text] [Related]
12. Role of peroxisome proliferator-activated receptor-gamma in maintenance of the characteristics of mature 3T3-L1 adipocytes. Tamori Y; Masugi J; Nishino N; Kasuga M Diabetes; 2002 Jul; 51(7):2045-55. PubMed ID: 12086932 [TBL] [Abstract][Full Text] [Related]
13. A single element in the phosphoenolpyruvate carboxykinase gene mediates thiazolidinedione action specifically in adipocytes. Glorian M; Duplus E; Beale EG; Scott DK; Granner DK; Forest C Biochimie; 2001 Oct; 83(10):933-43. PubMed ID: 11728630 [TBL] [Abstract][Full Text] [Related]
14. Trichostatin A modulates thiazolidinedione-mediated suppression of tumor necrosis factor α-induced lipolysis in 3T3-L1 adipocytes. Lu JC; Chang YT; Wang CT; Lin YC; Lin CK; Wu ZS PLoS One; 2013; 8(8):e71517. PubMed ID: 23951179 [TBL] [Abstract][Full Text] [Related]
15. Thiazolidinedione-induced activation of the transcription factor peroxisome proliferator-activated receptor gamma in cells adjacent to the murine skeletal muscle: implications for fibroblast functions. Löhrke B; Shahi SK; Krüger B; Schmidt P; Renne U; Dietl G Pflugers Arch; 2000 Jan; 439(3):288-96. PubMed ID: 10650980 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of adipogenesis by a COOH-terminally truncated mutant of PPARgamma2 in 3T3-L1 cells. Masugi J; Tamori Y; Kasuga M Biochem Biophys Res Commun; 1999 Oct; 264(1):93-9. PubMed ID: 10527847 [TBL] [Abstract][Full Text] [Related]
17. PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. Schoonjans K; Peinado-Onsurbe J; Lefebvre AM; Heyman RA; Briggs M; Deeb S; Staels B; Auwerx J EMBO J; 1996 Oct; 15(19):5336-48. PubMed ID: 8895578 [TBL] [Abstract][Full Text] [Related]